Centre Testing International Group Co. Ltd.(300012.SZ)
No price history available.
Key financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CNYm | 3,568 | 4,329 | 5,131 | 5,605 | 6,084 | 6,621 | N/A | N/A |
| Operating profit | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | CNYm | 578 | 746 | 903 | 910 | 921 | 1,016 | N/A | N/A |
| EPS reported | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | CNYm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | CNY | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in CNY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Centre Testing International Group Co. Ltd. (CTI) delivers a comprehensive suite of testing, calibration, inspection, certification, and technical services, operating across China and globally. The company's operations are divided into four key segments: Life Science, Trade Guarantee, Consumer Goods, and Industrial Test. CTI's extensive service portfolio includes specialized testing for hazardous substances, general safety, electromagnetic compatibility (EMC), and environmental safety. They also perform reliability and failure analysis for electronics and various materials (both metallic and nonmetallic), alongside dedicated product testing for textiles, footwear, leather goods, toys, and automotive materials and components. Furthermore, CTI offers in-depth testing, inspection, and compliance checks for food products, pharmaceuticals, cosmetics, animal feed, and food contact materials. Additional services encompass auditing, precise measurement calibration, dimensional inspection, semiconductor testing, management of hazardous materials in maritime shipping, freight assessment, certification programs, training courses, and the development and testing of application software. The company serves a broad spectrum of industries, including electrical and electronic products, building materials and engineering, maritime, metrology, food and drug, vehicle manufacturing, metal materials and parts, as well as hardline goods, toys, textiles, footwear, and leather products. Established in 2003, Centre Testing International Group Co. Ltd. is headquartered in Shenzhen, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Centre Testing International Group Co. Ltd. (300012.SZ)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Centre Testing International Group Co. Ltd. (CTI) delivers a comprehensive suite of testing, calibration, inspection, certification, and technical services, operating across China and globally. The company's operations are divided into four key segments: Life Science, Trade Guarantee, Consumer Goods, and Industrial Test. CTI's extensive service portfolio includes specialized testing for hazardous substances, general safety, electromagnetic compatibility (EMC), and environmental safety. They also perform reliability and failure analysis for electronics and various materials (both metallic and nonmetallic), alongside dedicated product testing for textiles, footwear, leather goods, toys, and automotive materials and components. Furthermore, CTI offers in-depth testing, inspection, and compliance checks for food products, pharmaceuticals, cosmetics, animal feed, and food contact materials. Additional services encompass auditing, precise measurement calibration, dimensional inspection, semiconductor testing, management of hazardous materials in maritime shipping, freight assessment, certification programs, training courses, and the development and testing of application software. The company serves a broad spectrum of industries, including electrical and electronic products, building materials and engineering, maritime, metrology, food and drug, vehicle manufacturing, metal materials and parts, as well as hardline goods, toys, textiles, footwear, and leather products. Established in 2003, Centre Testing International Group Co. Ltd. is headquartered in Shenzhen, China.
